Showing results (1-10 of 139) with videos related to

Sort By:
Pageof 14
Nederlands Tijdschrift Voor Geneeskunde|September 30, 2009
[Diagnostic image; a man with severe radiation dermatitis]Geert O R J Janssens, Carla M L van Herpen
Critical Reviews in Oncology/Hematology|June 29, 2015
Pretreatment body mass index and head and neck cancer outcome: A review of the literatureDide den Hollander, Ellen Kampman, Carla M L van Herpen
Pediatric Blood & Cancer|August 24, 2010
Temsirolimus for metastatic desmoplastic small round cell tumorAnna M J Thijs, Winette T A van der Graaf, Carla M L van Herpen
The Lancet. Oncology|March 16, 2010
PET-CT for response assessment and treatment adaptation in head and neck cancerJohan Bussink, Carla M L van Herpen, Johannes H A M Kaanders, et al.
Applied Health Economics and Health Policy|July 17, 2022
Economic Evaluation of a Tumour-Agnostic Therapy: Dutch Economic Value of Larotrectinib in TRK Fusion-Positive CancersRenée E Michels, Carlos H Arteaga, Michel L Peters, et al.
Frontiers in Medicine|November 4, 2021
Case Report: Two Cases of Salivary Duct Carcinoma in Workers With a History of Chromate ExposureImran Seçin, Maike J M Uijen, Chantal M L Driessen, et al.
Oral Oncology|August 19, 2019
Health-related quality of life of patients treated with chemoradiotherapy plus or minus prophylactic antibiotics to reduce the number of pneumonias for locally advanced head and neck cancer, the PANTAP studyJanneke C Ham, Carla M L van Herpen, Chantal M L Driessen, et al.
Acta Oncologica (Stockholm, Sweden)|December 23, 2010
A phase I study of recombinant human interleukin-21 (rIL-21) in combination with sunitinib in patients with metastatic renal cell carcinoma (RCC)Viktor Grünwald, Ingrid M E Desar, John Haanen, et al.
Anti-Cancer Drugs|December 1, 2012
Pharmacokinetics and tolerability of cediranib, a potent VEGF signalling inhibitor, in cancer patients with hepatic impairmentCarla M L van Herpen, Ulrik Lassen, Ingrid M E Desar, et al.
Cancer Treatment Reviews|October 24, 2019
Advances and challenges in precision medicine in salivary gland cancerGerben Lassche, Wim van Boxtel, Marjolijn J L Ligtenberg, et al.
Pageof 14